Fakultni Nemocnice Hradec Kralove

At Fakultni Nemocnice Hradec Kralove, research in urology and related oncology areas focuses on cancers of the urinary and male reproductive systems, especially renal cell carcinoma and prostate cancer. These studies are designed to compare new treatment approaches with current standards and to improve long-term outcomes for people with advanced or high-risk disease.

• Advanced and metastatic renal cell carcinoma
• High-risk localized or locally advanced prostate cancer
• High-risk and locally advanced prostate cancer after surgery or radiation

The site is contributing to trials that evaluate whether newer therapies can better control disease progression, reduce recurrence, and improve survival in difficult-to-treat cancers.

A major part of the clinical trial portfolio involves hematology and lymphoma research, with studies in chronic lymphocytic leukemia, follicular lymphoma, marginal zone lymphoma, diffuse large B-cell lymphoma, and Hodgkin lymphoma. These trials aim to test more effective treatment combinations, improve response rates, and support longer disease control in both newly diagnosed and relapsed settings.

• Chronic lymphocytic leukemia and small lymphocytic lymphoma
• Follicular lymphoma and marginal zone lymphoma
• Diffuse large B-cell lymphoma and Hodgkin lymphoma

The research also includes efforts to refine treatment selection and improve outcomes after prior therapy, reflecting a strong focus on personalized blood cancer care.

The site also supports trials in immune system diseases and nervous system diseases, including multiple sclerosis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, and juvenile idiopathic arthritis. These studies are aimed at understanding how newer therapies may reduce inflammation, improve symptoms, and help patients maintain function over time.

• Relapsing and progressive multiple sclerosis
• Psoriatic arthritis and axial spondyloarthritis
• Crohn’s disease and juvenile idiopathic arthritis

This area of research includes both safety and effectiveness studies, with a clear emphasis on better disease control for chronic immune-mediated conditions.

Clinical trials at the site cover important cardiovascular diseases and nutritional and metabolic diseases, including acute myocardial infarction, acute coronary syndrome, heart failure, atherosclerotic cardiovascular disease, and severe hypertriglyceridemia. The goal is to evaluate therapies that may lower cardiovascular risk, prevent recurrent events, and improve outcomes in people with inflammation-related heart disease.

• Acute coronary syndrome and acute myocardial infarction
• Heart failure with preserved or mildly reduced ejection fraction
• Atherosclerotic cardiovascular disease and elevated lipoprotein(a)

These studies reflect a strong interest in prevention as well as treatment, particularly for patients at high risk of future cardiac complications.

Research in respiratory tract diseases includes chronic obstructive pulmonary disease and different forms of asthma, along with hereditary angioedema as an immune-related condition. The studies are focused on whether newer treatments can reduce flare-ups, improve symptom control, and lessen dependence on long-term rescue or maintenance medicines.

• Chronic obstructive pulmonary disease
• Severe asthma and oral corticosteroid-dependent asthma
• Hereditary angioedema

This part of the portfolio highlights practical goals such as better day-to-day breathing, fewer exacerbations, and improved quality of life.

The site’s broader trial activity also includes skin and connective tissue diseases, eye diseases, and selected female urogenital diseases. Studies involve melanoma, psoriasis, macular edema, and endometrial cancer, showing a wide-ranging effort to assess new therapies and improve disease control across several specialties.

• Melanoma and chronic plaque psoriasis
• Macular edema secondary to retinal vein occlusion
• Mismatch-repair deficient high-risk endometrial cancer

These trials are generally aimed at improving treatment effectiveness, delaying recurrence, or preserving vision and skin health in conditions with substantial impact on daily life.

Additional work at Fakultni Nemocnice Hradec Kralove includes studies in hemic and lymphatic diseases, congenital and hereditary disorders, and digestive system and oral physiological phenomena. Important topics include primary IgA nephropathy, Alport syndrome, immune thrombocytopenia, and knee cartilage defects. The purpose of these trials is to explore new treatment options and better support for chronic or inherited conditions.

• Primary IgA nephropathy and Alport syndrome
• Immune thrombocytopenia
• Knee cartilage defect repair

This research demonstrates a broad clinical interest in both organ-specific disease management and regenerative approaches.